Reviewed,
UniProtKB/Swiss-Prot O43918 (AIRE_HUMAN)
Last modified
January 19, 2010.
Version 108.
History...
Clusters with 100%,
90%,
50% identity |
Documents (6) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Autoimmune regulator Alternative name(s): Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein Short name=APECED protein | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 545 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Transcriptional regulator that binds to DNA as a dimer or as a tetramer, but not as a monomer. Binds to G-doublets in an A/T-rich environment; the preferred motif is a tandem repeat of 5'-. ATTGGTTA-3' combined with a 5'-TTATTA-3' box. Binds to nucleosomes By similarity. Binds to chromatin and interacts selectively with histone H3 that is not methylated at 'Lys-4', not phosphorylated at 'Thr-3' and not methylated at 'Arg-2'. Functions as a sensor of histone H3 modifications that are important for the epigenetic regulation of gene expression. Functions as a transcriptional activator and promotes the expression of otherwise tissue-specific self-antigens in the thymus, which is important for self tolerance and the avoidance of autoimmune reactions. Ref.10 |
| Subunit structure | Homodimer and homotetramer. Interacts with CREBBP. Interacts preferentially with histone H3 that is not methylated at 'Lys-4'. Binds with lower affinity to histone H3 that is monomethylated at 'Lys-4'. Trimethylation of histone H3 at 'Lys-4' or phosphorylation at 'Thr-3' abolish the interaction. Binds with lower affinity to histone H3 that is acetylated at 'Lys-4', or that is acetylated at 'Lys-9' or trimethylated at 'Lys-9'. Binds histone H3 that is dimethylated at 'Arg-2' with very low affinity. Ref.10 Ref.6 Ref.12 |
| Subcellular location | Nucleus. Cytoplasm. Note: Associated with tubular structures and in discrete nuclear dots resembling ND10 nuclear bodies. May shuttle between nucleus and cytoplasm. Ref.5 Ref.7 Ref.8 Ref.9 |
| Tissue specificity | Widely expressed. Expressed at higher level in thymus (medullary epithelial cells and monocyte-dendritic cells), pancreas, adrenal cortex and testis. Expressed at lower level in the spleen, fetal liver and lymph nodes. Isoform 2 and isoform 3 seem to be less frequently expressed than isoform 1, if at all. |
| Domain | The L-X-X-L-L repeats may be implicated in binding to nuclear receptors. The HSR domain is required for localization on tubular structures (N-terminal part) and for homodimerization. Interacts via the first PHD domain with the N-terminus of histone H3 that is not methylated at 'Lys-4'. Disruption of the first PHD domain has been shown to lead to reduced transcriptional activity and to localization of the protein mainly in the cytoplasm in small granules. While the PHD zinc fingers are necessary for the transactivation capacity of the protein, other regions also modulate this function. |
| Post-translational modification | Phosphorylated. Phosphorylation could trigger oligomerization. Ref.6 |
| Involvement in disease | Defects in AIRE are a cause of autoimmune poly-endocrinopathy candidiasis ectodermal dystrophy (APECED) [MIM:240300]; also known as autoimmune polyglandular syndrome type I (APS-1). APECED is an autosomal recessive disease characterized by: (1) autoimmune polyendocrinopathies: hypoparathyroidism, adrenocortical failure, IDDM, gonadal failure, hypothyroidism, pernicious anemia, and hepatitis; (2) chronic mucocutaneous candidiasis; (3) ectodermal dystrophies: vitiligo, alopecia, keratopathy, dystrophy of dental enamel, nails and tympanic membranes. In addition, a high proportion of patients develop squamous cell carcinoma of the oral mucosa. The disease is reported worldwide but is exceptionally prevalent among the Finnish population (incidence 1:25000) and the Iranian jews (incidence 1:9000). Ref.10 Ref.7 Ref.8 Ref.9 Ref.1 Ref.11 Ref.13 Ref.14 Ref.16 Ref.17 Ref.18 Ref.19 Ref.20 Ref.21 Ref.22 Ref.23 Ref.24 Ref.25 Most of the mutations alter the nucleus-cytoplasm distribution of AIRE and disturb its association with nuclear dots and cytoplasmic filaments. Most of the mutations also decrease transactivation of the protein. The HSR domain is responsible for the homomultimerization activity of AIRE. All the missense mutations of the HSR and the SAND domains decrease this activity, but those in other domains do not. The AIRE protein is present in soluble high-molecular-weight complexes. Mutations in the HSR domain and deletion of PHD zinc fingers disturb the formation of these complexes. |
| Sequence similarities | Contains 1 HSR domain. Contains 2 PHD-type zinc fingers. Contains 1 SAND domain. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| ABL1 | P00519 | 1 | EBI-1753081,EBI-375543 | |
| CRK | P46108 | 1 | EBI-1753081,EBI-886 | |
| FYN | P06241 | 1 | EBI-1753081,EBI-515315 | |
| GRB2 | P62993 | 1 | EBI-1753081,EBI-401755 | |
| NCK1 | P16333 | 1 | EBI-1753081,EBI-389883 | |
| PIK3R1 | P27986 | 1 | EBI-1753081,EBI-79464 | |
| PLCG1 | P19174 | 1 | EBI-1753081,EBI-79387 | |
| SRC | P12931 | 1 | EBI-1753081,EBI-621482 |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] Note: Additional isoforms seem to exist. Experimental confirmation may be lacking for some isoforms. | ||||||
| Isoform 1 (identifier: O43918-1) Also known as: AIRE-1; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: O43918-2) Also known as: AIRE-2; The sequence of this isoform differs from the canonical sequence as follows: 1-292: MATDAALRRL...LALPSDPQLH → MWLVYSSGAP...VALRRVLHPS | ||||||
| Isoform 3 (identifier: O43918-3) Also known as: AIRE-3; The sequence of this isoform differs from the canonical sequence as follows: 1-292: MATDAALRRL...LALPSDPQLH → MWLVYSSGAP...VALRRVLHPS 377-545: VRGPPGEPLA...MARPAAPFPS → PRCQGWTPRP...ACAADPAQET |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||
Molecule processing | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 545 | 545 | Autoimmune regulator | PRO_0000064513 | ||||||||||||
Regions | ||||||||||||||||
| Domain | 1 – 105 | 105 | HSR | |||||||||||||
| Domain | 181 – 280 | 100 | SAND | |||||||||||||
| Zinc finger | 296 – 343 | 48 | PHD-type 1 | |||||||||||||
| Zinc finger | 434 – 475 | 42 | PHD-type 2 | |||||||||||||
| Region | 295 – 298 | 4 | Interaction with histone H3 not methylated at 'Lys-4' | |||||||||||||
| Region | 304 – 312 | 9 | Interaction with histone H3 not methylated at 'Lys-4' | |||||||||||||
| Region | 331 – 335 | 5 | Interaction with histone H3 not methylated at 'Lys-4' | |||||||||||||
| Motif | 7 – 11 | 5 | LXXLL motif 1 | |||||||||||||
| Motif | 63 – 67 | 5 | LXXLL motif 2 | |||||||||||||
| Motif | 414 – 418 | 5 | LXXLL motif 3 | |||||||||||||
| Motif | 516 – 520 | 5 | LXXLL motif 4 | |||||||||||||
Natural variations | ||||||||||||||||
| Alternative sequence | 1 – 292 | 292 | MATDA…DPQLH → MWLVYSSGAPGTQQPARNRV FFPIGMAPGGVCWRPDGWGT GGQGRISGPGSMGAGQRLGS SGTQRCCWGSCFGKEVALRR VLHPS in isoform 2 and isoform 3. | VSP_004089 | ||||||||||||
| Alternative sequence | 377 – 545 | 169 | VRGPP…APFPS → PRCQGWTPRPCTPYCVWVLR VSRTWLLVRVAGCAEMVRTC CGVLTAPLPSTGAATSQPAP PGPGRACAADPAQET in isoform 3. | VSP_004090 | ||||||||||||
| Natural variant | 15 | 1 | R → C in APECED. Ref.21 | VAR_026480 | ||||||||||||
| Natural variant | 15 | 1 | R → L in APECED; enzymatic activity of approximately 30% of that of the wild-type. Ref.9 Ref.17 Ref.24 | VAR_013713 | ||||||||||||
| Natural variant | 16 | 1 | T → M in APECED; enzymatic activity of approximately 10% of that of the wild-type. Ref.9 Ref.17 Ref.18 Ref.24 | VAR_013714 | ||||||||||||
| Natural variant | 21 | 1 | A → V in APECED. Ref.9 Ref.23 | VAR_026481 | ||||||||||||
| Natural variant | 22 – 23 | 2 | Missing in APECED; lack of alpha-galactosidase enzymatic activity; lack of homodimerization. | VAR_026482 | ||||||||||||
| Natural variant | 28 | 1 | L → P in APECED; abolishes association with cytoplasmic tubular structures and homodimerization. Ref.8 Ref.9 Ref.14 Ref.17 | VAR_005004 | ||||||||||||
| Natural variant | 29 | 1 | L → P in APECED. Ref.9 Ref.20 | VAR_013715 | ||||||||||||
| Natural variant | 77 | 1 | F → S in APECED; lack of alpha-galactosidase enzymatic activity; lack of homodimerization. Ref.24 | VAR_026483 | ||||||||||||
| Natural variant | 78 | 1 | W → R in APECED; lack of alpha-galactosidase enzymatic activity; lack of homodimerization. Ref.9 Ref.17 Ref.18 Ref.22 Ref.24 | VAR_013716 | ||||||||||||
| Natural variant | 80 | 1 | V → L in APECED. Ref.7 Ref.9 Ref.17 | VAR_013717 | ||||||||||||
| Natural variant | 83 | 1 | K → E in APECED. Ref.9 Ref.1 Ref.17 | VAR_005005 | ||||||||||||
| Natural variant | 85 | 1 | Y → C in APECED. Ref.7 Ref.17 Ref.23 | VAR_013718 | ||||||||||||
| Natural variant | 90 | 1 | Y → C in APECED. Ref.9 Ref.17 | VAR_013719 | ||||||||||||
| Natural variant | 93 | 1 | L → R in APECED. Ref.9 Ref.17 | VAR_013720 | ||||||||||||
| Natural variant | 228 | 1 | G → W in APECED; changes the subcellular localization and in addition disrupts the transactivating capacity of the wild-type AIRE; acts with a dominant negative effect by binding to the wild-type AIRE thus preventing the protein from forming the complexes needed for transactivation. Ref.9 Ref.19 Ref.25 | VAR_014422 | ||||||||||||
| Natural variant | 252 | 1 | P → L in APECED. dbSNP rs34397615. Ref.22 | VAR_026484 | ||||||||||||
| Natural variant | 278 | 1 | S → R: dbSNP rs1800520. Ref.17 Ref.15 | VAR_005006 | ||||||||||||
| Natural variant | 301 | 1 | V → M in APECED; no effect on protein structure or on interaction with histone H3. Ref.10 Ref.11 Ref.13 Ref.17 | VAR_013721 | ||||||||||||
| Natural variant | 305 | 1 | G → S | VAR_013722 | ||||||||||||
| Natural variant | 311 | 1 | C → Y in APECED; impairs zinc binding and folding of the PHD-type 1 zinc finger. Ref.10 Ref.7 Ref.11 Ref.13 Ref.17 Ref.23 | VAR_013723 | ||||||||||||
| Natural variant | 326 | 1 | P → L in APECED; no significant effect on structure, but may alter protein interactions. Ref.13 Ref.16 | VAR_026485 | ||||||||||||
| Natural variant | 326 | 1 | P → Q in APECED; alters folding of the PHD-type 1 zinc finger. Ref.7 Ref.9 Ref.11 Ref.13 Ref.17 | VAR_013724 | ||||||||||||
| Natural variant | 539 | 1 | P → L in APECED. Ref.22 | VAR_026486 | ||||||||||||
Experimental info | ||||||||||||||||
| Mutagenesis | 295 | 1 | N → A: Abolishes interaction with histone H3. Ref.12 | |||||||||||||
| Mutagenesis | 297 | 1 | D → A: Strongly reduces interaction with unmethylated histone H3 and abolishes interaction with histone H3 trimethylated at 'Lys-4'. Ref.10 | |||||||||||||
| Mutagenesis | 298 | 1 | E → A: Reduces interaction with histone H3. Ref.12 | |||||||||||||
| Mutagenesis | 302 | 1 | C → P: Reduces transcriptional activation. Ref.8 | |||||||||||||
| Mutagenesis | 303 | 1 | R → P: Alters protein folding and abolishes interaction with histone H3. Ref.12 | |||||||||||||
| Mutagenesis | 304 | 1 | D → A: Strongly reduces interaction with histone H3. Ref.12 | |||||||||||||
| Mutagenesis | 307 | 1 | E → A: Reduces interaction with histone H3. Ref.12 | |||||||||||||
| Mutagenesis | 312 | 1 | D → A: Abolishes interaction with histone H3. Ref.10 | |||||||||||||
| Mutagenesis | 437 | 1 | C → P: Reduces transcription activation. Ref.8 | |||||||||||||
| Sequence conflict | 437 – 467 | 31 | CGDGT…TSRPG → W in CAA08759. Ref.3 | |||||||||||||
Secondary structure | ||||||||||||||||
Helix Strand Turn | ||||||||||||||||
| Beta strand | 298 – 303 | 6 | ||||||||||||||
| Turn | 320 – 322 | 3 | ||||||||||||||
| Beta strand | 323 – 325 | 3 | ||||||||||||||
| Helix | 338 – 342 | 5 | ||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Positional cloning of the APECED gene." Nagamine K., Peterson P., Scott H.S., Kudoh J., Minoshima S., Heino M., Krohn K.J.E., Lalioti M.D., Mullis P.E., Antonarakis S.E., Kawasaki K., Asakawa S., Ito F., Shimizu N. Nat. Genet. 17:393-398(1997) [PubMed: 9398839] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1; 2 AND 3), VARIANT APECED GLU-83. Tissue: Thymus. |
| [2] | "An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains." Aaltonen J., Bjoerses P., Perheentupa J., Horelli-Kuitunen N., Palotie A., Peltonen L., Lee Y.S., Francis F., Hennig S., Thiel C., Lehrach H., Yaspo M.-L. Nat. Genet. 17:399-403(1997) [PubMed: 9398840] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1). Tissue: Thymus. |
| [3] | Lee Y.S., Francis F., Hennig S., Thiel C., Reinhard R., Lehrach H., Yaspo M.-L. Submitted (JUL-1998) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [4] | "The DNA sequence of human chromosome 21." Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T., Park H.-S., Toyoda A., Ishii K., Totoki Y., Choi D.-K., Groner Y., Soeda E., Ohki M., Takagi T., Sakaki Y., Taudien S., Blechschmidt K., Polley A. Yaspo M.-L.Nature 405:311-319(2000) [PubMed: 10830953] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "Localization of the APECED protein in distinct nuclear structures." Bjoerses P., Pelto-Huikko M., Kaukonen J., Aaltonen J., Peltonen L., Ulmanen I. Hum. Mol. Genet. 8:259-266(1999) [PubMed: 9931333] [Abstract] Cited for: SUBCELLULAR LOCATION. |
| [6] | "The autoimmune regulator (AIRE) is a DNA-binding protein." Kumar P.G., Laloraya M., Wang C.-Y., Ruan Q.-G., Davoodi-Semiromi A., Kao K.-J., She J.-X. J. Biol. Chem. 276:41357-41364(2001) [PubMed: 11533054] [Abstract] Cited for: PARTIAL PROTEIN SEQUENCE, SUBUNIT STRUCTURE, DNA-BINDING, PHOSPHORYLATION. |
| [7] | "Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein." Bjeorses P., Halonen M., Palvimo J.J., Kolmer M., Aaltonen J., Ellonen P., Perheentupa J., Ulmanen I., Peltonen L. Am. J. Hum. Genet. 66:378-392(2000) [PubMed: 10677297] [Abstract] Cited for: SUBCELLULAR LOCATION, VARIANTS APECED LEU-80; CYS-85; TYR-311 AND GLN-326. |
| [8] | "Subcellular localization of the autoimmune regulator protein. characterization of nuclear targeting and transcriptional activation domain." Pitkaenen J., Vaehaemurto P., Krohn K.J.E., Peterson P. J. Biol. Chem. 276:19597-19602(2001) [PubMed: 11274163] [Abstract] Cited for: SUBCELLULAR LOCATION, TRANSCRIPTION ACTIVATION, MUTAGENESIS OF CYS-302 AND CYS-437, CHARACTERIZATION OF VARIANT APECED PRO-28. |
| [9] | "APECED-causing mutations in AIRE reveal the functional domains of the protein." Halonen M., Kangas H., Rueppell T., Ilmarinen T., Ollila J., Kolmer M., Vihinen M., Palvimo J., Saarela J., Ulmanen I., Eskelin P. Hum. Mutat. 23:245-257(2004) [PubMed: 14974083] [Abstract] Cited for: SUBCELLULAR LOCATION, CHARACTERIZATION OF VARIANTS APECED LEU-15; MET-16; VAL-21; PRO-28; PRO-29; ARG-78; LEU-80; GLU-83; CYS-90; ARG-93; TRP-228 AND GLN-326. |
| [10] | "The autoimmune regulator PHD finger binds to non-methylated histone H3K4 to activate gene expression." Org T., Chignola F., Hetenyi C., Gaetani M., Rebane A., Liiv I., Maran U., Mollica L., Bottomley M.J., Musco G., Peterson P. EMBO Rep. 9:370-376(2008) [PubMed: 18292755] [Abstract] Cited for: INTERACTION WITH HISTONE H3 NON-METHYLATED OR MONO-METHYLATED AT LYS-4, FUNCTION, MUTAGENESIS OF ASP-297 AND ASP-312, CHARACTERIZATION OF VARIANTS APECED MET-301 AND TYR-311. |
| [11] | "NMR structure of the first PHD finger of autoimmune regulator protein (AIRE1). Insights into autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) disease." Bottomley M.J., Stier G., Pennacchini D., Legube G., Simon B., Akhtar A., Sattler M., Musco G. J. Biol. Chem. 280:11505-11512(2005) [PubMed: 15649886] [Abstract] Cited for: STRUCTURE BY NMR OF 293-354 IN COMPLEX WITH ZINC IONS, CHARACTERIZATION OF VARIANTS APECED MET-301; TYR-311 AND GLN-326. |
| [12] | "The solution structure of the first PHD finger of autoimmune regulator in complex with non-modified histone H3 tail reveals the antagonistic role of H3R2 methylation." Chignola F., Gaetani M., Rebane A., Org T., Mollica L., Zucchelli C., Spitaleri A., Mannella V., Peterson P., Musco G. Nucleic Acids Res. 37:2951-2961(2009) [PubMed: 19293276] [Abstract] Cited for: STRUCTURE BY NMR OF 293-354 IN COMPLEX WITH ZINC IONS AND UNMETHYLATED HISTONE H3 N-TERMINUS, MASS SPECTROMETRY, MUTAGENESIS OF ASN-295; GLU-298; ARG-303; ASP-304 AND GLU-307, INTERACTION WITH HISTOME H3. |
| [13] | "Structure and site-specific recognition of histone H3 by the PHD finger of human autoimmune regulator." Chakravarty S., Zeng L., Zhou M.-M. Structure 17:670-679(2009) [PubMed: 19446523] [Abstract] Cited for: STRUCTURE BY NMR OF 294-347 IN COMPLEX WITH ZINC IONS AND UNMETHYLATED HISTONE H3 N-TERMINUS, CHARACTERIZATION OF VARIANTS APECED MET-301; TYR-311; LEU-326 AND GLN-326. |
| [14] | "Mutation analyses of North American APS-1 patients." Heino M., Scott H.S., Chen Q., Peterson P., Maeenpaeae U., Papasavvas M.-P., Mittaz L., Barras C., Rossier C., Chrousos G.P., Stratakis C.A., Nagamine K., Kudoh J., Shimizu N., Maclaren N., Antonarakis S.E., Krohn K.J.E. Hum. Mutat. 13:69-74(1999) [PubMed: 9888391] [Abstract] Cited for: VARIANT APECED PRO-28. |
| [15] | "Common mutations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients of different origins." Scott H.S., Heino M., Peterson P., Mittaz L., Lalioti M.D., Betterle C., Cohen A., Seri M., Lerone M., Romeo G., Collin P., Salo M., Metcalfe R., Weetman A., Papasavvas M.-P., Rossier C., Nagamine K., Kudoh J. Antonarakis S.E.Mol. Endocrinol. 12:1112-1119(1998) [PubMed: 9717837] [Abstract] Cited for: VARIANT ARG-278. |
| [16] | "Identification of a novel mutation in the autoimmune regulator (AIRE-1) gene in a French family with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy." Saugier-Veber P., Drouot N., Wolf L.M., Kuhn J.M., Frebourg T., Lefebvre H. Eur. J. Endocrinol. 144:347-351(2001) [PubMed: 11275943] [Abstract] Cited for: VARIANT APECED LEU-326. |
| [17] | "APECED mutations in the autoimmune regulator (AIRE) gene." Heino M., Peterson P., Kudoh J., Shimizu N., Antonarakis S.E., Scott H.S., Krohn K.J.E. Hum. Mutat. 18:205-211(2001) [PubMed: 11524731] [Abstract] Cited for: VARIANTS APECED LEU-15; MET-16; PRO-28; PR0-29; ARG-78; LEU-80; GLU-83; CYS-85; CYS-90; ARG-93; MET-301; TYR-311 AND GLN-326, VARIANT ARG-278. |
| [18] | "Novel AIRE mutations and P450 cytochrome autoantibodies in Central and Eastern European patients with APECED." The MEWPE-APECED study group Cihakova D., Trebusak K., Heino M., Fadeyev V., Tiulpakov A., Battelino T., Tar A., Halasz Z., Bluemel P., Tawfik S., Krohn K., Lebl J., Peterson P. Hum. Mutat. 18:225-232(2001) [PubMed: 11524733] [Abstract] Cited for: VARIANTS APECED MET-16 AND ARG-78. |
| [19] | "A novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, acting in a dominant fashion and strongly cosegregating with hypothyroid autoimmune thyroiditis." Cetani F., Barbesino G., Borsari S., Pardi E., Cianferotti L., Pinchera A., Marcocci C. J. Clin. Endocrinol. Metab. 86:4747-4752(2001) [PubMed: 11600535] [Abstract] Cited for: VARIANT APECED TRP-228. |
| [20] | "Distinct clinical phenotype and immunoreactivity in Japanese siblings with autoimmune polyglandular syndrome type 1 (APS-1) associated with compound heterozygous novel AIRE gene mutations." Kogawa K., Kudoh J., Nagafuchi S., Ohga S., Katsuta H., Ishibashi H., Harada M., Hara T., Shimizu N. Clin. Immunol. 103:277-283(2002) [PubMed: 12173302] [Abstract] Cited for: VARIANT APECED PRO-29. |
| [21] | "A novel missense mutation of AIRE gene in a patient with autoimmune polyendocrinopathy, candidiasis and ectodermal dystrophy (APECED), accompanied with progressive muscular atrophy: case report and review of the literature in Japan." Sato K., Nakajima K., Imamura H., Deguchi T., Horinouchi S., Yamazaki K., Yamada E., Kanaji Y., Takano K. Endocr. J. 49:625-633(2002) [PubMed: 12625412] [Abstract] Cited for: VARIANT APECED CYS-15. |
| [22] | "Delineation of the molecular defects in the AIRE gene in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients from Southern Italy." Meloni A., Perniola R., Faa V., Corvaglia E., Cao A., Rosatelli M.C. J. Clin. Endocrinol. Metab. 87:841-846(2002) [PubMed: 11836330] [Abstract] Cited for: VARIANTS APECED ARG-78; LEU-252 AND LEU-539. |
| [23] | "AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype." Halonen M., Eskelin P., Myhre A.-G., Perheentupa J., Husebye E.S., Kaempe O., Rorsman F., Peltonen L., Ulmanen I., Partanen J. J. Clin. Endocrinol. Metab. 87:2568-2574(2002) [PubMed: 12050215] [Abstract] Cited for: VARIANTS APECED VAL-21; CYS-85 AND TYR-311. |
| [24] | "Two novel mutations of the AIRE protein affecting its homodimerization properties." Meloni A., Fiorillo E., Corda D., Perniola R., Cao A., Rosatelli M.C. Hum. Mutat. 25:319-319(2005) [PubMed: 15712268] [Abstract] Cited for: VARIANTS APECED 22-VAL-ASP-23 DEL; SER-77 AND ARG-78, CHARACTERIZATION OF VARIANTS APECED LEU-15; MET-16; 22-VAL-ASP-23 DEL; SER-77 AND ARG-78. |
| [25] | "Functional analysis of SAND mutations in AIRE supports dominant inheritance of the G228W mutation." Ilmarinen T., Eskelin P., Halonen M., Rueppell T., Kilpikari R., Torres G.D., Kangas H., Ulmanen I. Hum. Mutat. 26:322-331(2005) [PubMed: 16114041] [Abstract] Cited for: CHARACTERIZATION OF VARIANT APECED TRP-228. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AB006682 mRNA. Translation: BAA23988.1. AB006683 mRNA. Translation: BAA23989.1. AB006684 Genomic DNA. Translation: BAA23990.1. AB006684 Genomic DNA. Translation: BAA23991.1. AB006684 Genomic DNA. Translation: BAA23992.1. AB006685 mRNA. Translation: BAA23993.1. Z97990 mRNA. Translation: CAB10790.1. AJ009610 Genomic DNA. Translation: CAA08759.1. AP001754 Genomic DNA. Translation: BAA95560.1. | ||||||||||||||||||||||||
| IPI | IPI00015149. IPI00031178. IPI00031188. | ||||||||||||||||||||||||
| RefSeq | NP_000374.1. NP_000649.1. | ||||||||||||||||||||||||
| UniGene | Hs.129829 | ||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||
| SMR | O43918. Positions 191-261, 296-476. | ||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||
| IntAct | O43918. 8 interactions. | ||||||||||||||||||||||||
| STRING | O43918. | ||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||
| PhosphoSite | O43918. | ||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||
| PRIDE | O43918. | ||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||
| Ensembl | ENST00000291582; ENSP00000291582; ENSG00000160224; Homo sapiens. [Genome view] | ||||||||||||||||||||||||
| GeneID | 326. | ||||||||||||||||||||||||
| KEGG | hsa:326. | ||||||||||||||||||||||||
| NMPDR | fig|9606.3.peg.21064. | ||||||||||||||||||||||||
| UCSC | uc002zei.1. human. | ||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||
| CTD | 326. | ||||||||||||||||||||||||
| GeneCards | GC21P044530. | ||||||||||||||||||||||||
| H-InvDB | HIX0040838. | ||||||||||||||||||||||||
| HGNC | HGNC:360. AIRE. | ||||||||||||||||||||||||
| MIM | 109100. phenotype. 240300. phenotype. 607358. gene. | ||||||||||||||||||||||||
| Orphanet | 3453. Autoimmune polyendocrinopathy, type 1. | ||||||||||||||||||||||||
| PharmGKB | PA24654. | ||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||
| eggNOG | prNOG12893. | ||||||||||||||||||||||||
| HOGENOM | HBG445904. | ||||||||||||||||||||||||
| HOVERGEN | O43918. | ||||||||||||||||||||||||
| InParanoid | O43918. | ||||||||||||||||||||||||
| OMA | STAILDF. | ||||||||||||||||||||||||
| OrthoDB | EOG90VZ89. | ||||||||||||||||||||||||
| PhylomeDB | O43918. | ||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||
| ArrayExpress | O43918. | ||||||||||||||||||||||||
| Bgee | O43918. | ||||||||||||||||||||||||
| CleanEx | HS_AIRE. | ||||||||||||||||||||||||
| Genevestigator | O43918. | ||||||||||||||||||||||||
| GermOnline | ENSG00000160224. Homo sapiens. | ||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||
| InterPro | IPR008087. AIRE. IPR000770. SAND. IPR010919. SAND-like. IPR004865. Sp100. IPR019786. Zinc_finger_PHD-type_CS. IPR011011. Znf_FYVE_PHD. IPR001965. Znf_PHD. IPR019787. Znf_PHD-finger. [Graphical view] | ||||||||||||||||||||||||
| Pfam | PF00628. PHD. 1 hit. PF01342. SAND. 1 hit. PF03172. Sp100. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| PRINTS | PR01711. AIREGULATOR. | ||||||||||||||||||||||||
| SMART | SM00249. PHD. 2 hits. SM00258. SAND. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| PROSITE | PS51414. HSR. 1 hit. PS50864. SAND. 1 hit. PS01359. ZF_PHD_1. 2 hits. PS50016. ZF_PHD_2. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||
Other Resources | |||||||||||||||||||||||||
| NextBio | 1337. | ||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||
Entry information
| Entry name | AIRE_HUMAN | ||||||||
| Accession | Primary (citable) accession number: O43918 Secondary accession number(s): O43922, O43932, O75745 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 21 Human chromosome 21: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


